STAT+: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines
STAT
FEBRUARY 28, 2024
It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.
Let's personalize your content